Back to Search
Start Over
Mitochondrial functional impairment in ARL3 -mutation related rod-cone dystrophy.
- Source :
-
FASEB bioAdvances [FASEB Bioadv] 2024 Sep 09; Vol. 6 (11), pp. 555-564. Date of Electronic Publication: 2024 Sep 09 (Print Publication: 2024). - Publication Year :
- 2024
-
Abstract
- Mitochondria are vital for retinal cell function and survival, and there is growing evidence linking mitochondrial dysfunction to retinal degenerations. Although ARL3 mutations have been linked to multiple forms of retinal degeneration, the relationship between ARL3 and mitochondria remains unexplored. Herein, we investigated the effects of ARL3 <superscript> T31A </superscript> , ARL3 <superscript> C118F </superscript> , and ARL3 <superscript> T31A/C118F </superscript> mutations on mitochondrial function in fibroblasts obtained from patients with ARL3-related rod-cone dystrophy. Our findings revealed that these mutations led to a decrease in mitochondrial respiration, an increase in the accumulation mitochondrial reactive oxygen species (ROS), and induction of apoptosis in fibroblasts. Additionally, we conducted a comparative analysis of the effects of ARL3 <superscript>T31A</superscript> , ARL3 <superscript>C118F</superscript> , and ARL3 <superscript>T31A/C118F</superscript> proteins on mitochondria in ARPE-19 cells. Results showed that ARL3 <superscript>T31A</superscript> and ARL3 <superscript>T31A/C118F</superscript> not only affected mitochondrial function but also induced apoptosis in ARPE-19 cells. Conversely, ARL3 <superscript>C118F</superscript> primarily influenced cell apoptosis with minimal effects on mitochondrial function in ARPE-19 cells. Transcriptome analysis further suggested the involvement of respiratory electron transport, response to ROS, and apoptotic signaling pathways in ARL3 <superscript>T31A/C118F</superscript> cells. Our study demonstrated that ARL3 -related mutations play a significant role in the diversity of mitochondrial function, providing novel insights into the functional analysis of ARL3 -related mutations.<br />Competing Interests: The authors declare no conflict of interest.<br /> (© 2024 The Author(s). FASEB BioAdvances published by Wiley Periodicals LLC on behalf of The Federation of American Societies for Experimental Biology.)
Details
- Language :
- English
- ISSN :
- 2573-9832
- Volume :
- 6
- Issue :
- 11
- Database :
- MEDLINE
- Journal :
- FASEB bioAdvances
- Publication Type :
- Academic Journal
- Accession number :
- 39512837
- Full Text :
- https://doi.org/10.1096/fba.2023-00138